Iwase R - Search Results

1

Double Percutaneous Transesophageal Gastrotubing for Gastric Cancer: A Pilot Study.

Iwase R, Suzuki Y, Yamanouchi E, Suzuki N, Imakita T, Tsutsui N, Odaira H, Yanaga K. Iwase R, et al. J Surg Res. 2018 Dec;232:470-474. doi: 10.1016/j.jss.2018.05.041. Epub 2018 Jul 25. J Surg Res. 2018. PMID: 30463759

2

Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice.

Haruki K, Shiba H, Fujiwara Y, Furukawa K, Iwase R, Uwagawa T, Misawa T, Ohashi T, Yanaga K. Haruki K, et al. Among authors: iwase r. Dig Dis Sci. 2013 Jan;58(1):123-31. doi: 10.1007/s10620-012-2311-4. Epub 2012 Jul 18. Dig Dis Sci. 2013. PMID: 22806547

3

Prognostic factors of unresectable pancreatic cancer treated with nafamostat mesilate combined with gemcitabine chemotherapy.

Furukawa K, Uwagawa T, Iwase R, Haruki K, Fujiwara Y, Gocho T, Shiba H, Misawa T, Yanaga K. Furukawa K, et al. Among authors: iwase r. Anticancer Res. 2012 Nov;32(11):5121-6. Anticancer Res. 2012. PMID: 23155291 Clinical Trial.

4

Inhibition of nuclear factor kappa-B enhances the antitumor effect of combination treatment with tumor necrosis factor-alpha gene therapy and gemcitabine for pancreatic cancer in mice.

Fujiwara Y, Shiba H, Iwase R, Haruki K, Furukawa K, Uwagawa T, Misawa T, Ohashi T, Yanaga K. Fujiwara Y, et al. Among authors: iwase r. J Am Coll Surg. 2013 Feb;216(2):320-32.e3. doi: 10.1016/j.jamcollsurg.2012.09.016. Epub 2012 Dec 5. J Am Coll Surg. 2013. PMID: 23219147

5

Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer.

Gocho T, Uwagawa T, Furukawa K, Haruki K, Fujiwara Y, Iwase R, Misawa T, Ohashi T, Yanaga K. Gocho T, et al. Among authors: iwase r. Cancer Lett. 2013 Jun 1;333(1):89-95. doi: 10.1016/j.canlet.2013.01.019. Epub 2013 Jan 21. Cancer Lett. 2013. PMID: 23348695

6

Glasgow prognostic score predicts therapeutic outcome after pancreaticoduodenectomy for carcinoma of the ampulla of vater.

Shiba H, Misawa T, Fujiwara Y, Futagawa Y, Furukawa K, Haruki K, Iwase R, Wakiyama S, Ishida Y, Yanaga K. Shiba H, et al. Among authors: iwase r. Anticancer Res. 2013 Jun;33(6):2715-21. Anticancer Res. 2013. PMID: 23749931

7

Negative impact of fresh-frozen plasma transfusion on prognosis after hepatic resection for liver metastases from colorectal cancer.

Shiba H, Ishida Y, Haruki K, Furukawa K, Fujiwara Y, Iwase R, Ohkuma M, Ogawa M, Misawa T, Yanaga K. Shiba H, et al. Among authors: iwase r. Anticancer Res. 2013 Jun;33(6):2723-8. Anticancer Res. 2013. PMID: 23749932

8

Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.

Iwase R, Haruki K, Fujiwara Y, Furukawa K, Shiba H, Uwagawa T, Misawa T, Ohashi T, Yanaga K. Iwase R, et al. J Surg Res. 2013 Sep;184(1):605-12. doi: 10.1016/j.jss.2013.06.003. Epub 2013 Jun 25. J Surg Res. 2013. PMID: 23830367

9

Post-operative lymphocyte count may predict the outcome of radical resection for gallbladder carcinoma.

Iwase R, Shiba H, Haruki K, Fujiwara Y, Furukawa K, Futagawa Y, Wakiyama S, Misawa T, Yanaga K. Iwase R, et al. Anticancer Res. 2013 Aug;33(8):3439-44. Anticancer Res. 2013. PMID: 23898116

10

Inhibition of nuclear factor-κB enhances the antitumor effect of tumor necrosis factor-α gene therapy for hepatocellular carcinoma in mice.

Haruki K, Shiba H, Fujiwara Y, Furukawa K, Iwase R, Uwagawa T, Misawa T, Ohashi T, Yanaga K. Haruki K, et al. Among authors: iwase r. Surgery. 2013 Sep;154(3):468-78. doi: 10.1016/j.surg.2013.05.037. Surgery. 2013. PMID: 23972653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters